Status:
COMPLETED
Clinical Trial to Evaluate the Pharmacokinetic Characteristics of DW5221 and DW5221-R
Lead Sponsor:
Daewon Pharmaceutical Co., Ltd.
Conditions:
Apetite Stimulants
Eligibility:
MALE
19-55 years
Phase:
PHASE1
Brief Summary
A bioequivalence study to compare and evaluate the pharmacokinetic characteristics and the safety after administration of DW5221 and DW5221-R in healthy adult m ale volunteers
Eligibility Criteria
Inclusion
- Healthy Male Volunteers who are ≥19 years old
- Body weight ≥50.0 kg and BMI between 18.0 and 30.0 kg/m2 and
Exclusion
- Clinically significant Medical History
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 17 2022
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT06147908
Start Date
July 1 2022
End Date
November 17 2022
Last Update
November 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chungbuk National University Hospital
Cheongju-si, South Korea